Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGRONOMICS LIMITED Net Asset Value 2015

Jul 30, 2015

7474_rns_2015-07-30_6988f400-5634-4e59-94ae-b6f21eaaad14.html

Net Asset Value

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4818U

Port Erin Biopharma Investments Ltd

30 July 2015

7.00am 30 July 2015

Port Erin Biopharma Investments Limited

(the "Company")

Net Asset Value calculation to 30 June 2015

Jim Mellon, Chairman, commented: -

"The Net Asset Value ("NAV") calculation for the Company as at closing on 30 June 2015 was 11.47 pence per share, including un-invested cash of £255,564. The portfolio is valued under IFRS at bid price.

Net Assets stand at £2.7 million including Investments of £2.5 million. This quarter's NAV represents a decrease of 6.9% from the previous valuation of 12.32 pence per share, which included un-invested cash of £405,665. On this basis, no additional management fee is due to Shellbay Investments Limited.

The reported NAV to 30 June 2015 suffered due to some adverse foreign exchange fluctuations in our holdings on translation to the sterling reporting currency.  The underlying value of our investments in unaffected by these accounting movements and has no cash impact. The portfolio continues to demonstrate strong fundamentals, including Plethora Solutions Holdings plc which enjoyed an uplift of 21% over the quarter."

Unaudited to 30 June 2015    £
Fixed Assets
Investments 2,454,953
Current Assets
Sundry Debtors 11,846
Uninvested cash 255,564
Current Liabilities
Creditors: amounts due (61,600)
2,660,763
Capital and Reserves
Share Capital 23
Share Premium 1,890,142
Reserves 770,598
2,660,763
Shares in Issue 23,195,558
Net Asset Value per share 11.47 pence

Portfolio Details

Investments as at 30 June 2015 Value % of Total Portfolio
Magna Biopharma Income Fund £1,238,846 50.5%
Plethora Solutions Holdings £310,000 12.6%
Summit Corporation £408,150 16.6%
Other quoted holdings £188,665 7.7%
Other unquoted holdings £309,292 12.6%
Total £2,454,953 100.0%

For further information, please contact:

Port Erin Biopharma

Investments Limited
Beaumont Cornish Limited Peterhouse Capital Limited
The Company Nomad Broker
Denham Eke

(+44) (0) 1624 639396
Roland Cornish

(+44) (0) 207 628 3396
Lucy Williams

(+44) (0) 207 469 0936

This information is provided by RNS

The company news service from the London Stock Exchange

END

NAVFMGZNKLVGKZM